​

CureVac (CVAC) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

CVAC Stock Forecast

CureVac (CVAC) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a -7.75% decline from the last price of $5.42.

High: $5 Avg: $5 Low: $5 Last Closed Price: $5.42

CVAC Stock Rating

CureVac stock's rating consensus is Hold, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (25.00%), 5 Hold (62.50%), 1 Sell (12.50%), and 0 Strong Sell (0.00%).

Hold
Total 8 0 1 5 2 Strong Sell Sell Hold Buy Strong Buy

CVAC Price Target Upside V Benchmarks

TypeNameUpside
StockCureVac-7.75%
SectorHealthcare Stocks 18.80%
IndustryBiotech Stocks 54.28%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$5.00$5.00
Last Closing Price$5.42$5.42$5.42
Upside/Downside--7.75%-7.75%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 25-15--6
Jun, 25122-16
May, 25122-16
Apr, 25122-16
Mar, 25132-17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 12, 2025Roger SongJefferies$5.00$5.60-10.71%-7.75%
Jan 07, 2023Eun YangJefferies$21.00$8.26154.24%287.45%
Apr 22, 2022JMP Securities$37.00$16.79120.37%582.66%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 26, 2025UBSNeutraldowngrade
Jun 12, 2025JefferiesBuyHolddowngrade
Jun 12, 2025CitigroupMarket Performdowngrade
Jan 07, 2023JefferiesBuyupgrade
Nov 17, 2022JMP SecuritiesMarket OutperformMarket Outperformhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.98$-2.21$-1.32------
Avg Forecast$-2.36$-3.23$-0.92$-0.71$0.79$-0.51$-0.28$-0.36$-0.20
High Forecast$-2.09$-2.86$-0.84$-0.46$0.86$0.16$-0.13$-0.17$-0.10
Low Forecast$-2.62$-3.59$-1.01$-0.96$0.72$-0.99$-0.43$-0.56$-0.31
Surprise %-58.47%-31.58%43.48%------

Revenue Forecast

$0 $110M $220M $330M $440M $550M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$48.90M$102.99M$67.42M$52.70M-----
Avg Forecast$71.41M$66.32M$60.96M$55.27M$517.95M$65.31M$135.75M$149.75M$144.69M
High Forecast$77.64M$72.11M$65.39M$77.58M$525.69M$91.68M$190.55M$210.20M$203.10M
Low Forecast$65.18M$60.53M$56.83M$32.95M$510.21M$38.94M$80.94M$89.28M$86.27M
Surprise %-31.52%55.28%10.60%-4.66%-----

Net Income Forecast

$-800M $-600M $-400M $-200M $0 $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-129.07M$-411.72M$-249.03M------
Avg Forecast$-520.52M$-712.84M$-202.82M$-157.57M$175.13M$-112.69M$-62.23M$-80.44M$-44.69M
High Forecast$-461.44M$-631.94M$-184.94M$-102.21M$189.73M$34.67M$-29.57M$-38.22M$-21.23M
Low Forecast$-579.58M$-793.73M$-222.00M$-212.93M$158.11M$-219.60M$-94.89M$-122.65M$-68.14M
Surprise %-75.20%-42.24%22.79%------

CVAC Forecast FAQ

Is CureVac stock a buy?

CureVac stock has a consensus rating of Hold, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that CureVac is a neutral investment for most analysts.

What is CureVac's price target?

CureVac's price target, set by 8 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential -7.75% change from the previous closing price of $5.42.

How does CureVac stock forecast compare to its benchmarks?

CureVac's stock forecast shows a -7.75% downside, underperforming the average forecast for the healthcare stocks sector (18.80%) and underperforming the biotech stocks industry (54.28%).

What is the breakdown of analyst ratings for CureVac over the past three months?

  • July 2025: 0% Strong Buy, 16.67% Buy, 83.33% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 16.67% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 16.67% Strong Sell.
  • May 2025: 16.67% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 16.67% Strong Sell.

What is CureVac’s EPS forecast?

CureVac's average annual EPS forecast for its fiscal year ending in December 2024 is $0.79, marking a 0% decrease from the reported $0 in 2023. Estimates for the following years are $-0.51 in 2025, $-0.28 in 2026, $-0.36 in 2027, and $-0.2 in 2028.

What is CureVac’s revenue forecast?

CureVac's average annual revenue forecast for its fiscal year ending in December 2024 is $517.95M, reflecting a 882.88% increase from the reported $52.7M in 2023. The forecast for 2025 is $65.31M, followed by $135.75M for 2026, $149.75M for 2027, and $144.69M for 2028.

What is CureVac’s net income forecast?

CureVac's net income forecast for the fiscal year ending in December 2024 stands at $175.13M, representing a 0% decrease from the reported $0 in 2023. Projections indicate $-113M in 2025, $-62.233M in 2026, $-80.441M in 2027, and $-44.688M in 2028.